Ledger.Open graph →
SEC Form D · Amendment · filed February 9, 2010

Aegerion Pharmaceuticals, Inc

Offering
$16.8M
Sold
$16.8M
Exemption
—
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

People & firms on this filing (18)

Antonio M. Gotto · Bridgewater, NJDirectorAlison De Bord · Bridgewater, NJDirectorWilliam Sasiela · Bridgewater, NJExecWilliam H. Lewis · Bridgewater, NJExecJason Fisherman · Bridgewater, NJDirectorChristine Pellizzari · Bridgewater, NJExecPeter Garrambone · Bridgewater, NJDirectorMichele Ollier · Bridgewater, NJDirectorDavid Scheer · Bridgewater, NJDirectorMichael Finney · Boston, MAExecAlf Bjorseth · Oslo, Q8ExecBjorge Gretland · Oslo, Q8ExecMike Janse · Palo Alto, CADirectorAl Schuele · Dallas, TXDirectorPaul Vais · Menlo Park, CADirectorClinton Bybee · Chicago, ILDirectorKevin Kent · Irvine, CADirectorBruce A. Brown · Kennesaw, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗